Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2017 (pdf):
download in single page format - double page (broad) format

Publication overview

Current news and events

Tor Erik Rusten's research presented:Autophagy - Hope or Threat to Cancer Patients?

Tor Erik Rusten (photo: Berit Langaard, OUS)

Tor Erik Rusten is heading the Tumor-Host Biology research group at the Department of Molecular Cell Biology at the Institute for Cancer Research. His research on autophagy has recently (May 23rd) been presented in a feature article in popular science form, published on the Oslo University Hospital home page (in Norwegian), entitled "Autophagy - Hope or Threat to Cancer Patients?".

Radforsk to invest NOK 4.5 million in cancer research

Anette Weyergang

Radforsk is an evergreen investor focusing on companies that develop cancer treatment. Since its start-up in 1986, Radforsk has ploughed NOK 200 million of its profit back into cancer research at Oslo University Hospital. This year, four researchers will be awarded a total of NOK 4.5 million. One of them is Anette Weyergang, who will receive NOK 3.75 million over a three-year period.

The first Norwegian CAR

Made in Oslo by a team of researchers from Oslo University Hospital, the first ever Norwegian CAR T cell is now a fact. A potential treatment based on this result depends on a clinical study.
The CAR (Chimeric Antigen Receptor) construct was designed, manufactured and validated in two laboratories in the Radium Hospital campus. One is headed by Else Marit Inderberg and Sébastien Wälchli and the other is led by June Helen Myklebust and Erlend B. Smeland.

Successful kick-off for new collaboration between Institute for Cancer Research and Institut Curie

Cancer researchers from Institute for Cancer Research, Oslo, and Institut Curie, Paris, held a successful kick-off seminar in Paris on March 25th, followed by a reception with Norway’s ambassador in France.

Thanks to a generous donation from Trond S. Paulsen, a new collaboration between ICR and Institut Curie, Paris, was opened. The funded project, “Mechanisms of cancer cell invasion” (InvaCell), is a collaboration between the groups of Harald Stenmark, ICR, and Philippe Chavrier, Institut Curie.

Units and subpages

View all subunitsHide all subunits